Full Text View
Tabular View
No Study Results Posted
Related Studies
Motivating Factors That Play a Role in Bulimia Nervosa
This study is currently recruiting participants.
Study NCT00304174   Information provided by National Institute of Mental Health (NIMH)
First Received: March 15, 2006   Last Updated: September 18, 2009   History of Changes

March 15, 2006
September 18, 2009
May 2005
April 2013   (final data collection date for primary outcome measure)
  • Breakpoint [ Time Frame: Measured at Day 3 ] [ Designated as safety issue: No ]
  • Total work performed on progressive task [ Time Frame: Measured at Day 3 ] [ Designated as safety issue: No ]
  • Breakpoint [ Time Frame: Measured at Day 3 ]
  • Total work performed on progressive task [ Time Frame: Measured at Day 3 ]
Complete list of historical versions of study NCT00304174 on ClinicalTrials.gov Archive Site
 
 
 
Motivating Factors That Play a Role in Bulimia Nervosa
Translational Research on Eating Disorders: Behavioral Assessment of Motivation to Eat

This study will evaluate whether people with bulimia nervosa will binge eat in a structured laboratory setting and display behavioral patterns similar to those of individuals who are dependent on drugs.

Bulimia nervosa (BN) is a serious eating disorder that is characterized by frequent uncontrolled eating binges. These binges are often followed by compensatory behavior, including the following: self-induced vomiting; misuse of laxatives, diuretics, enemas, or other medications to induce purging; fasting; or excessive exercise. If left untreated, BN can lead to many serious health issues: tooth decay; irregular menstruation; bowel damage; constipation; heart and kidney disease; intestinal damage; puffiness, especially in the face and fingers; increased hair growth on the face and body; and mineral imbalances in the body. Similar to drug abuse disorders, food-related thinking and disordered eating behavior can interfere with other occupational and social activities, as well. This study will evaluate whether people with bulimia nervosa will binge eat in a structured laboratory setting and display behavioral patterns similar to those of individuals who are dependent on drugs.

Interested participants will first report to the study site for a screening visit, during which they will be assessed for eligibility using blood tests and an interview. Eligible participants will return to the study site on 3 additional days. Participants will be asked to refrain from eating or drinking between 10 P.M. each night before reporting to the study site and 10 A.M. the next day. Each day, participants will receive breakfast, after which they will not be allowed to eat or drink until the end of the day. Participants will then use a computer program to earn food (a yogurt shake) by tapping on the keyboard. More taps on the keyboard will result in a larger amount of food earned by the end of the day. Once experimentation is complete on Day 1, participants will be instructed to eat as much as they can. On Days 2 and 3, participants will be given a small serving of the yogurt shake prior to beginning the computer task. Following the computer task, they will be instructed to either eat until they are comfortable (without restricting or binging), or eat as much as they can. A private bathroom will be available if needed. All participants, including those who did not meet criteria for participation, will be offered treatment at the study clinic once the study is complete.

 
Observational
Case Control, Prospective
  • Bulimia Nervosa
  • Eating Disorders
Behavioral: Motivation to eat
  • Participants with bulimia nervosa
  • Control participants without bulimia nervosa who weigh between 80% and 120% of ideal weight
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
32
April 2013
April 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

Participants with Bulimia Nervosa:

  • Meets DSM-IV criteria for bulimia nervosa
  • Duration of illness is greater than 1 year
  • Self-induces vomiting
  • Weighs between 80% and 120% of ideal weight

Control Group:

  • Weighs between 80% and 120% of ideal weight

Exclusion Criteria:

Participants with Bulimia Nervosa:

  • Significant medical illness
  • Current Axis I illness other than major depression
  • Severe or very severe depression
  • At risk for suicide
  • Currently taking medication
  • History of drug or alcohol abuse within the 6 months prior to study entry
  • Pregnant

Control Group:

  • Significant medical illness
  • Currently taking medication
  • History of drug or alcohol abuse within the 6 months prior to study entry
  • Pregnant
  • Current or history of psychiatric illness
  • History of any eating disorder
Both
18 Years to 45 Years
Yes
Contact: Eating Disorders Clinic 212-543-5739 edru@pi.cpmc.columbia.edu
United States
 
NCT00304174
B. Timothy Walsh, MD, The New York State Psychiatric Institute
R21 MH065024-05, DNBBS 72-NBR
National Institute of Mental Health (NIMH)
 
Principal Investigator: B. T. Walsh, MD New York State Psychiatric Institute at Columbia University Medical Center
National Institute of Mental Health (NIMH)
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP